Cargando…

Metabolism and disposition of MM-433593, a selective FAAH-1 inhibitor, in monkeys

MM-433593 is a highly potent and selective inhibitor of fatty acid amide hydrolase-1 (FAAH-1) with potential utility as an orally administered treatment of pain, inflammation, and other disorders. In this study, we investigated the metabolism and pharmacokinetics of MM-433593 in monkeys, and compare...

Descripción completa

Detalles Bibliográficos
Autores principales:	Banijamali, Ali R, Wakefield, James D, Mermerian, Ara H, Busby, Robert W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2014
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186420/ https://www.ncbi.nlm.nih.gov/pubmed/25505606 http://dx.doi.org/10.1002/prp2.59

Ejemplares similares

FAAH inhibitors in the limelight, but regrettably
por: Mallet, Christophe, et al.
Publicado: (2016)

FAAH selectively influences placebo effects
por: Peciña, M., et al.
Publicado: (2013)

Expression and localization of CB1R, NAPE-PLD, and FAAH in the vervet monkey nucleus accumbens
por: Kucera, Ryan, et al.
Publicado: (2018)

Disposition and metabolism of [(14)C]-levomilnacipran, a serotonin and norepinephrine reuptake inhibitor, in humans, monkeys, and rats
por: Brunner, Valérie, et al.
Publicado: (2015)

Hexafluoroisopropyl Carbamates as Selective MAGL and Dual MAGL/FAAH Inhibitors: Biochemical and Physicochemical Properties
por: Barth, Maximilian, et al.
Publicado: (2022)

Potential Therapeutic Value of a Novel FAAH Inhibitor for the Treatment of Anxiety
por: Marco, Eva M., et al.
Publicado: (2015)

Analgesic effects of FAAH inhibitor in the insular cortex of nerve-injured rats
por: Jee Kim, Min, et al.
Publicado: (2018)

Redox system and phospholipid metabolism in the kidney of hypertensive rats after FAAH inhibitor URB597 administration
por: Biernacki, Michał, et al.
Publicado: (2017)

The endocannabinoid hydrolase FAAH is an allosteric enzyme
por: Dainese, Enrico, et al.
Publicado: (2020)

The selective reversible FAAH inhibitor, SSR411298, restores the development of maladaptive behaviors to acute and chronic stress in rodents
por: Griebel, Guy, et al.
Publicado: (2018)

Beyond the Canonical Endocannabinoid System. A Screening of PPAR Ligands as FAAH Inhibitors
por: Brunetti, Leonardo, et al.
Publicado: (2020)

Activity of FAAH-Inhibitor JZP327A in an Experimental Rat Model of Migraine
por: Greco, Rosaria, et al.
Publicado: (2023)

A polymorphism in the gene of the endocannabinoid-degrading enzyme FAAH (FAAH C385A) is associated with emotional–motivational reactivity
por: Conzelmann, Annette, et al.
Publicado: (2012)

Equipement et disposition des ensembles de securite vide (mmHg)
por: Burlet, A
Publicado: (1967)

The FAAH Inhibitor URB597 Modulates Lipid Mediators in the Brain of Rats with Spontaneous Hypertension
por: Biernacki, Michał, et al.
Publicado: (2020)

Role of FAAH-Like Anandamide Transporter in Anandamide Inactivation
por: Leung, KwanNok, et al.
Publicado: (2013)

Author Correction: The endocannabinoid hydrolase FAAH is an allosteric enzyme
por: Dainese, Enrico, et al.
Publicado: (2020)

Molecular basis of FAAH-OUT-associated human pain insensitivity
por: Mikaeili, Hajar, et al.
Publicado: (2023)

Therapeutic endocannabinoid augmentation for mood and anxiety disorders: comparative profiling of FAAH, MAGL and dual inhibitors
por: Bedse, Gaurav, et al.
Publicado: (2018)

Potential application of endocannabinoid system agents in neuropsychiatric and neurodegenerative diseases—focusing on FAAH/MAGL inhibitors
por: Ren, Si-yu, et al.
Publicado: (2020)

Identifying FAAH Inhibitors as New Therapeutic Options for the Treatment of Chronic Pain through Drug Repurposing
por: Zanfirescu, Anca, et al.
Publicado: (2021)

Selective serotonin reuptake inhibitors and venlafaxine in pregnancy: Changes in drug disposition
por: Westin, Andreas Austgulen, et al.
Publicado: (2017)

N-aryl 2-aryloxyacetamides as a new class of fatty acid amide hydrolase (FAAH) inhibitors
por: Sunduru, Naresh, et al.
Publicado: (2017)

Targeting the Endocannabinoid System for Neuroprotection: A (19)F-NMR Study of a Selective FAAH Inhibitor Binding with an Anandamide Carrier Protein, HSA
por: Zhuang, Jianqin, et al.
Publicado: (2013)

Molecular Basis for Non-Covalent, Non-Competitive FAAH Inhibition
por: Morgillo, Carmine Marco, et al.
Publicado: (2022)

FAAH inhibition ameliorates breast cancer in a murine model
por: Tripathy, Mallika, et al.
Publicado: (2023)

Correction: Selective serotonin reuptake inhibitors and venlafaxine in pregnancy: Changes in drug disposition
por: Westin, Andreas Austgulen, et al.
Publicado: (2018)

Metabolism and Disposition of the Novel Oral Factor XIa Inhibitor Asundexian in Rats and in Humans
por: Piel, Isabel, et al.
Publicado: (2023)

Endocannabinoid Regulation of Acute and Protracted Nicotine Withdrawal: Effect of FAAH Inhibition
por: Cippitelli, Andrea, et al.
Publicado: (2011)

FAAH genetic variation enhances fronto-amygdala function in mouse and human
por: Dincheva, Iva, et al.
Publicado: (2015)

A Swath Label-Free Proteomics insight into the Faah(−/−) Mouse Liver
por: Hamid, Zeeshan, et al.
Publicado: (2018)

Disposition and Metabolism of Setipiprant, a Selective Oral CRTH2 Antagonist, in Humans
por: Hoch, Matthias, et al.
Publicado: (2013)

Cocaine: analysis, pharmacokinetics, and metabolic disposition.
por: Jatlow, P.
Publicado: (1988)

Morphine metabolism, transport and brain disposition
por: De Gregori, Simona, et al.
Publicado: (2011)

Tryptophan metabolism, disposition and utilization in pregnancy
por: Badawy, Abdulla A.-B.
Publicado: (2015)

Species Differences in Tryptophan Metabolism and Disposition
por: Badawy, Abdulla A-B, et al.
Publicado: (2022)

Prediction of Deoxypodophyllotoxin Disposition in Mouse, Rat, Monkey, and Dog by Physiologically Based Pharmacokinetic Model and the Extrapolation to Human
por: Chen, Yang, et al.
Publicado: (2016)

MONitoring Knockbacks in EmergencY (MONKEY) – An Audit of Disposition Outcomes in Emergency Patients with Rejected Admission Requests
por: Zhang, Wendell, et al.
Publicado: (2022)

Peripheral Effects of FAAH Deficiency on Fuel and Energy Homeostasis: Role of Dysregulated Lysine Acetylation
por: Vaitheesvaran, Bhavapriya, et al.
Publicado: (2012)

The association of N-palmitoylethanolamine with the FAAH inhibitor URB597 impairs melanoma growth through a supra-additive action
por: Hamtiaux, Laurie, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_kbmeviuehod7qul9i8to6qb1ib